PT - JOURNAL ARTICLE AU - Adamopoulos, Dionysios AU - Rovas, Georgios AU - Johner, Nicolas AU - Müller, Hajo AU - Deux, Jean-François AU - Crowe, Lindsey A. AU - Vallée, Jean-Paul AU - Mach, François AU - Stergiopulos, Nikolaos AU - Shah, Dipen TI - Left atrial wall shear stress distribution correlates with atrial endocardial electrogram voltage and fibrosis in patients with atrial fibrillation AID - 10.1101/2024.07.11.24310174 DP - 2024 Jan 01 TA - medRxiv PG - 2024.07.11.24310174 4099 - http://medrxiv.org/content/early/2024/07/16/2024.07.11.24310174.short 4100 - http://medrxiv.org/content/early/2024/07/16/2024.07.11.24310174.full AB - Left atrial (LA) wall fibrosis plays an important role in the perpetuation of atrial fibrillation (AF) since the abnormal electrophysiological properties of the fibrotic areas sustains the arrhythmia by favoring both re-entry circuits as well as abnormal impulse generation. Despite its crucial contribution, the mechanisms by which LA fibrosis develops are not well understood.The LA wall is constantly exposed to the hydraulic forces exerted by the blood flow arriving from the pulmonary veins. The purpose of the present study was to examine the association between regional wall shear stress and areas with fibrosis in the LA of patients with AF.15 patients (13 males, mean age 61±11 years) with AF, no significant mitral regurgitation and clinical indication for a primary catheter ablation were prospectively recruited for the study. All participants underwent a baseline three-dimensional electro-anatomical mapping of the LA during the ablation procedure and a pre-interventional cardiovascular magnetic resonance (CMR) imaging with phase contrast for mitral flow estimation and Gadolinium injection for LA fibrosis detection. Fibrotic areas were detected either by low bipolar voltage (BV≤0.5mV) and/or by areas with enhanced late Gadolinium uptake as assessed by the image intensity ratio (IIR≥1.2). For all subjects, a detailed 3D anatomical model of the LA was extracted from the invasive electro-anatomical maps and was used to calculate regional time-averaged wall shear stress (TAWSS) and blood age (BA), an index of blood stagnation, by performing patient-specific computational fluid dynamic simulations.Globally, areas around the pulmonary veins and the LA roof exhibited the highest values of TAWSS. In all cases, high TAWSS was strongly correlated with low voltage (n=15, r from -0.002 to -0.449, p<0.01) and enhanced late Gadolinium uptake (n=12, r from 0.071 to 0.475, p<0.001). Fibrotic areas as detected by both low BV and high IIR were more prevalent in areas exposed to high TAWSS (21.6% vs 8.1% and 26.2% vs 13.2% respectively, p<0.001). Inversely, in all but one case, areas with low TAWSS presented more intense blood stagnation as assessed by the highest BA (r from -0.268 to - 0.688, p<0.001).In patients with AF, regional high TAWSS is associated with corresponding CMR biomarkers of left atrial wall fibrosis and electrical scaring. Inversely, areas with low TAWSS are associated with blood stagnation and could favor thrombus formation. This may provide insights of a novel pathophysiological mechanism explaining the characteristic atrial electrical remodeling and thrombus formation seen in patients with AF.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe project has been financially supported by Geneva University Hospitals (HUG D. Adamopoulos, Projet recherche et developpement).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Commission Cantonale d'Éthique de la Recherche sur l'être humain of the Canton of Geneva gave ethical approval for this work, approval number: 2023-02314.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data used in this study are available in the Manuscript and the Supplementary Material. The software is available at https://github.com/g-rov/lausm. https://github.com/g-rov/lausm